In their Review, Dr Sengupta and Dr Stone outline the assessment of ankylosing spondylitis in the ambulatory care setting and in response to treatment with tumor necrosis factor inhibitors. Although advances have been made in creating and validating outcome measures in this disease, the authors discuss the persistent need for suitable biomarkers to help with diagnosis and disease activity monitoring, in order to improve patient outcomes.
- Raj Sengupta
- Millicent A Stone
